Xcelera

Vendor:

First CVE: Nov 17, 2017 · Active for 8 years

3
Total CVEs
More Total CVEs than 64% of tracked products
1.5
Avg CVEs / Year
Higher CVE frequency than 56% of tracked products
7.2
Avg CVSS
Higher Avg CVSS than 45% of tracked products
0.0%
KEV Rate
Bottom 1%

Trends Over Time

The number and severity of CVEs published that impact Xcelera over time

Volume of CVEsAvg CVSS Base Score
First CVE
Nov 17, 2017
8 years ago
Most Recent CVE
Aug 22, 2018
2,893 days ago

CVE Severity & Scoring

Xcelera3 CVEs
All CVEs352,294 CVEs
MediumHigh
Attack Vector
Local2 (66.7%)
Network1 (33.3%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low3 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None3 (100.0%)
Unknown0 (0.0%)
Required0 (0.0%)
Privileges Required
Low1 (33.3%)
High2 (66.7%)
None0 (0.0%)
Unknown0 (0.0%)

Top CVEs

Signals from CVEs in this product scope (3 CVEs).

3 CVEs · Highest risk first

CVEPublishedCVSSRiskKEVExploit
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders whi
Aug 22, 20187.825NONO
The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if
Nov 17, 20177.224NONO
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been iden
Aug 22, 20186.723NONO

Exploit Exposure

Signals from CVEs in this product scope (3 CVEs).

CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%

Social Chatter

Signals from CVEs in this product scope (3 CVEs).

Media Mentions

Signals from CVEs in this product scope (3 CVEs).

Top CNAs Publishing CVEs For Xcelera

Top CWEs

Versions

No cataloged versions.